Flavonoids: Diet and Health Relationships

Summary Flavonoids and/or phenolic acids are the major components responsible for antioxidant capacity in fruits and vegetables. Recent research has shown that flavonoids are absorbed in humans, although the bioavailablity of these dietary components is not completely clear. Some epidemiological evidence demonstrates a reduced risk of cardio- and cerebrovascular diseases in subjects with a high fruit and vegetable (flavonoid) intake. Investigations performed in vitro or in vivo in experimental animals suggest that some of the flavonoids have chemopreventive effects against certain forms of cancers. Flavonoids are potentially beneficial to cardio- and cerebrovascular systems due to their antioxidant activity against low density lipoprotein (LDL) oxidation, inhibition of platelet aggregation, and protection against capillary fragility. Flavonoids showed anti-inflammatory, antiarthritic, and antiallergic activities in vitro, and, thus, may have potential applications in preventing and treating other diseases.

[1]  H. Kayahara,et al.  Synthesis and biological activities of ferulic acid derivatives. , 1999, Anticancer research.

[2]  J. R. Bell,et al.  Catechin is present as metabolites in human plasma after consumption of red wine. , 1999, The Journal of nutrition.

[3]  H. Shibata,et al.  Natural antioxidant, chlorogenic acid, protects against DNA breakage caused by monochloramine. , 1999, Bioscience, biotechnology, and biochemistry.

[4]  J. Steinberg.  Book ReviewAmbulatory Pediatric Care , 1989 .

[5]  R. Agarwal,et al.  Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. , 1999, Carcinogenesis.

[6]  O. Texier,et al.  Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids , 1996 .

[7]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[8]  A. Hara,et al.  Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. , 1999, Carcinogenesis.

[9]  C. Teng,et al.  Inhibition of platelet aggregation by some flavonoids. , 1991, Thrombosis research.

[10]  M. Steiner,et al.  Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. , 1984, Biochemical pharmacology.

[11]  J. Maclouf,et al.  Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. , 1985, Biochimica et biophysica acta.

[12]  C. Sen,et al.  Quercetin Inhibits Inducible Icam-1 Expression in Human Endothelial Cells through the Jnk Pathway Cells and Cell Culture , 2022 .

[13]  P. Chu,et al.  Particle-in-cell and Monte Carlo simulation of the hydrogen plasma immersion ion implantation process , 1999 .

[14]  Peter C. H. Hollman,et al.  Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands , 1992 .

[15]  M. Horwitt.  Observations on Behavior of the Anthocyan Pigment from Concord Grapes in the Animal Body , 1933 .

[16]  H. Mukhtar,et al.  Polyphenols as cancer chemopreventive agents , 1995, Journal of cellular biochemistry. Supplement.

[17]  I. Johnson,et al.  Quercetin glucosides interact with the intestinal glucose transport pathway. , 1998, Free radical biology & medicine.

[18]  R. Mohan,et al.  A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. , 1999, Cancer research.

[19]  C. Rice-Evans,et al.  Bioavailability of ferulic acid. , 1998, Biochemical and biophysical research communications.

[20]  I. Puddey,et al.  Chemistry And Biological Effects Of Dietary Phenolic Compounds: Relevance To Cardiovascular Disease , 2000, Clinical and experimental pharmacology & physiology.

[21]  C. Rice-Evans,et al.  The relative antioxidant activities of plant-derived polyphenolic flavonoids. , 1995, Free radical research.

[22]  G. Wong,et al.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. , 1991, Carcinogenesis.

[23]  R. Lamuela-Raventós,et al.  Detection of dietary antioxidant phenolic compounds in human LDL. , 1999, Clinical chemistry.

[24]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[25]  U. Fuhr,et al.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. , 1993, British journal of clinical pharmacology.

[26]  P. Hollman,et al.  Analysis and health effects of flavonoids , 1996 .

[27]  A. Szent-Gyorgyi.  Methods of preparing citrin. , 1938 .

[28]  E. Feskens,et al.  Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke: The Zutphen Study , 1996 .

[29]  R. Russell,et al.  Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. , 1998, The Journal of nutrition.

[30]  R. Prior,et al.  Anthocyanins are detected in human plasma after oral administration of an elderberry extract. , 1999, Clinical chemistry.

[31]  S. Booth,et al.  Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. , 1998, The American journal of clinical nutrition.

[32]  J. Kuhnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976 .

[33]  G. Lescoat,et al.  Role of flavonoids and iron chelation in antioxidant action. , 1994, Methods in enzymology.

[34]  P. Hollman,et al.  Absorption and disposition kinetics of the dietary antioxidant quercetin in man. , 1996, Free radical biology & medicine.

[35]  T. Whitehead,et al.  Effect of red wine ingestion on the antioxidant capacity of serum. , 1995, Clinical chemistry.

[36]  G. Beecher,et al.  Isoflavones in retail and institutional soy foods. , 1999, Journal of agricultural and food chemistry.

[37]  J. Folts,et al.  Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. , 1995, Circulation.

[38]  C. Rémésy,et al.  Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. , 1994, Cancer letters.

[39]  P. Belinky,et al.  The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. , 1998, Atherosclerosis.

[40]  L Bravo,et al.  Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. , 2009, Nutrition reviews.

[41]  M. Lean,et al.  Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. , 1998, The American journal of clinical nutrition.

[42]  A. Lavy,et al.  Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. , 1995, The American journal of clinical nutrition.

[43]  A. Hara,et al.  Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis , 1999, International journal of cancer.

[44]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[45]  G. Lescoat,et al.  Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.

[46]  P. Hollman,et al.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.

[47]  P C Elwood,et al.  Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. , 1997, The American journal of clinical nutrition.

[48]  Laishun Chen,et al.  Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[49]  E. Rimm,et al.  Relation between Intake of Flavonoids and Risk for Coronary Heart Disease in Male Health Professionals , 1996, Annals of Internal Medicine.

[50]  W. Bors,et al.  Flavonoids as antioxidants: determination of radical-scavenging efficiencies. , 1990, Methods in enzymology.

[51]  K. Miwa,et al.  Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. , 1997, The American journal of cardiology.

[52]  M. Heinonen,et al.  Anthocyanins as antioxidants on human low-density lipoprotein and lecithin-liposome systems , 1997 .

[53]  K. Croft.  The Chemistry and Biological Effects of Flavonoids and Phenolic Acids a , 1998, Annals of the New York Academy of Sciences.

[54]  A. Meyer,et al.  Antioxidant activity of berry phenolics on human low-density lipoprotein and liposome oxidation , 1998 .

[55]  T. Osawa,et al.  Protective effects of lemon flavonoids on oxidative stress in diabetic rats , 1998, Lipids.

[56]  J. Dwyer,et al.  Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. , 1998, Journal of the American Dietetic Association.

[57]  W. Mazur,et al.  Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). , 1998, The Journal of nutrition.

[58]  A. Hofman,et al.  Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. , 1999, Archives of internal medicine.

[59]  J. German,et al.  Effect of red wine on endothelium-dependent relaxation in rabbits. , 1997, Clinical science.

[60]  P. Hollman,et al.  Absorption, metabolism and health effects of dietary flavonoids in man. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[61]  O. Descamps,et al.  LDL oxidation: therapeutic perspectives. , 1998, Atherosclerosis.

[62]  N. Sekar,et al.  Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. , 1994, Cancer letters.

[63]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[64]  K. Nakagawa,et al.  Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. , 1999, Journal of agricultural and food chemistry.

[65]  B Havsteen,et al.  Flavonoids, a class of natural products of high pharmacological potency. , 1983, Biochemical pharmacology.

[66]  R. Rouseff,et al.  Flavanone absorption after naringin, hesperidin, and citrus administration , 1996, Clinical pharmacology and therapeutics.

[67]  C. Corbé,et al.  [Light vision and chorioretinal circulation. Study of the effect of procyanidolic oligomers (Endotelon)]. , 1988, Journal francais d'ophtalmologie.

[68]  M. Alcaraz,et al.  Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice. , 1994, Life sciences.

[69]  E. Middleton,et al.  Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.

[70]  D. Stansbie,et al.  Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. , 1997, Annals of nutrition & metabolism.

[71]  J. Kanner,et al.  Bioavailability of Red Wine Anthocyanins As Detected in Human Urine , 1998 .

[72]  P. Mattila,et al.  TROLOX EQUIVALENT ANTIOXIDANT CAPACITY OF AVERAGE FLAVONOIDS INTAKE IN FINLAND , 1999 .

[73]  A. Uchida,et al.  Induction of apoptosis by quercetin: involvement of heat shock protein. , 1994, Cancer research.

[74]  C. Rice-Evans,et al.  The identification of flavonoids as glycosides in human plasma , 1997, FEBS letters.

[75]  S. Kuo.  Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. , 1996, Cancer letters.

[76]  M. Miskulin,et al.  Influence of anthocyanoside treatment on the cholesterol-induced atherosclerosis in the rabbit. , 1979, Paroi arterielle.

[77]  M. Muldoon,et al.  Flavonoids and heart disease , 1996, BMJ.

[78]  J. Hassett,et al.  The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. , 1989, American journal of surgery.

[79]  S. Brown,et al.  The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. , 1992, Biochemical pharmacology.

[80]  W. Regelson,et al.  Review of the biology of Quercetin and related bioflavonoids. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[81]  J. D. del Río,et al.  Uses and properties of Citrus flavonoids , 1997 .

[82]  S. Nigdikar,et al.  Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. , 1998, The American journal of clinical nutrition.

[83]  R. Agarwal,et al.  Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3'-gallate as the most effective antioxidant constituent. , 1999, Carcinogenesis.

[84]  P. Morazzoni,et al.  Vaccinium myrtillus L. , 1996 .

[85]  R. Prior,et al.  Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. , 1997, Free radical biology & medicine.

[86]  S. Rankin,et al.  Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. , 1990, Biochemical pharmacology.